Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $25,000 | $0 | $0 | — | — | — | — | — | — | — |
| Research & development | $325 | $86,702 | $214,965 | $361,298 | $258,168 | — | — | — | — | — | — | — | — | — |
| Operating expenses | $1.7M | $2.6M | $2.4M | $4.7M | $4.1M | $953,493 | $2.9M | $1.0M | $2.1M | $719,868 | $358,656 | $405,045 | $505,812 | $934,208 |
| Operating income | −$1.7M | −$2.6M | −$2.4M | −$4.7M | −$4.1M | −$953,493 | −$2.9M | −$1.0M | −$2.1M | −$719,868 | −$358,656 | −$405,045 | −$505,812 | −$934,208 |
| Net income | −$1.3M | −$2.9M | −$3.3M | −$5.2M | −$3.4M | −$1.5M | −$1.8M | −$1.4M | −$1.8M | $634,090 | −$960,388 | −$1.4M | $1.1M | −$1.3M |
| Basic EPSper diluted share | — | — | — | — | -$0.00 | -$0.01 | -$0.08 | -$0.70 | -$0.01 | $0.15 | -$0.91 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | $0.00 | -$0.03 | — | — | -$0.00 | -$0.01 | -$0.08 | -$0.70 | -$0.01 | $0.01 | -$0.91 | $0.00 | $0.00 | $0.00 |